Combined molecular targeted drug therapy for EGFR and HER-2 in head and neck squamous cell carcinoma cell lines

Author：                  

Publisher： Spandidos Publications

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.40, Iss.6, 2012-01, pp. : 1805-1812

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bcl-2 Targeted-Therapy for the Treatment of Head and Neck Squamous Cell Carcinoma

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 45-57

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-EGFR Therapy: Strategies in Head and Neck Squamous Cell Carcinoma

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 2, 2016-04 ,pp. : 170-183

Bentham Science Publishers

Access to resources Recommend Favorite

Expression and Mutation Analysis of Her2 in Head and Neck Squamous Cell Carcinoma

By Ali Mahmoud AL Sheikh   Gunduz Mehmet   Gunduz Esra   Tamamura Ryo   Beder Levent Bekir   Katase Naoki   Hatipoglu Omer Faruk   Fukushima Kunihiro   Yamanaka Noboru   Shimizu Kenji   Nagatsuka Hitoshi  

Cancer Investigation, Vol. 28, Iss. 5, 2010-05 ,pp. : 495-500

Informa Healthcare

Access to resources Recommend Favorite

Establishment and characterization of triple drug resistant head and neck squamous cell carcinoma cell lines

By                

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-01 ,pp. : 3025-3032

Spandidos Publications

Access to resources Recommend Favorite

Expression and function of ABCG2 in head and neck squamous cell carcinoma and cell lines

By        

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-01 ,pp. : 1151-1157

Spandidos Publications

Access to resources Recommend Favorite